EUPRAXIA PHARMACEUTICALS INC (EPRX) Institutional Ownership Changes & 13F Activity
EUPRAXIA PHARMACEUTICALS INC (EPRX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q1 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Affinity Asset Advisors, Llc, Redmile Group, Llc, Rubric Capital Management Lp, Ikarian Capital, Llc, and Pfm Health Sciences, Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Ally Bridge Group (Ny) Llc | Buy | +262,480 | +66.0% | 660,375 | $4.78M | Q1 2026 | May 18, 2026 |
| Bank Of America Corp | Buy | +14,900 | +5.9% | 268,221 | $1.94M | Q1 2026 | May 18, 2026 |
| Redmile Group, Llc | Buy | +700,000 | — | 700,000 | $5.07M | Q1 2026 | May 15, 2026 |
| Rubric Capital Management Lp | Buy | +691,170 | — | 691,170 | $5.00M | Q1 2026 | May 15, 2026 |
| Ikarian Capital, Llc | Buy | +604,741 | +99.1% | 1,214,741 | $8.79M | Q1 2026 | May 15, 2026 |
| Pfm Health Sciences, Lp | Buy | +540,871 | — | 540,871 | $3.92M | Q1 2026 | May 15, 2026 |
| Woodline Partners Lp | Buy | +440,551 | — | 440,551 | $3.19M | Q1 2026 | May 15, 2026 |
| Seven Fleet Capital Management Lp | Buy | +433,515 | — | 433,515 | $3.14M | Q1 2026 | May 15, 2026 |
| Alyeska Investment Group, L.P. | Buy | +375,000 | — | 375,000 | $2.71M | Q1 2026 | May 15, 2026 |
| Dv Trading Llc | Buy | +276,000 | — | 276,000 | $2.00M | Q1 2026 | May 15, 2026 |
| Point72 Asset Management, L.P. | Buy | +255,471 | +35.9% | 967,575 | $7.01M | Q1 2026 | May 15, 2026 |
| Citadel Advisors Llc | Buy | +230,176 | — | 230,176 | $1.67M | Q1 2026 | May 15, 2026 |
| Squadron Capital Management Llc | Buy | +180,000 | +36.0% | 680,000 | $4.92M | Q1 2026 | May 15, 2026 |
| Boothbay Fund Management, Llc | Buy | +167,512 | +107.2% | 323,843 | $2.34M | Q1 2026 | May 15, 2026 |
| Summittx Capital, L.P. | Buy | +152,049 | +86.4% | 327,997 | $2.37M | Q1 2026 | May 15, 2026 |
| Royal Bank Of Canada | Buy | +65,099 | +33.2% | 261,376 | $1.89M | Q1 2026 | May 15, 2026 |
| Beutel, Goodman & Co Ltd. | Sell | -42,908 | -1.2% | 3,666,465 | $26.38M | Q1 2026 | May 15, 2026 |
| Diadema Partners Lp | Buy | +40,000 | — | 40,000 | $289.60K | Q1 2026 | May 15, 2026 |
| Toronto Dominion Bank | Buy | +32,898 | — | 32,898 | $237.48K | Q1 2026 | May 15, 2026 |
| Integrated Wealth Concepts Llc | Buy | +12,000 | — | 12,000 | $86.88K | Q1 2026 | May 15, 2026 |
| Geode Capital Management, Llc | Buy | +11,714 | +84.3% | 25,613 | $185.44K | Q1 2026 | May 15, 2026 |
| Two Sigma Investments, Lp | Buy | +10,800 | — | 10,800 | $78.19K | Q1 2026 | May 15, 2026 |
| Morgan Stanley | Buy | +8,820 | — | 8,820 | $63.86K | Q1 2026 | May 15, 2026 |
| Goldman Sachs Group Inc | Sell | -4,978 | -8.6% | 53,080 | $384.30K | Q1 2026 | May 15, 2026 |
| Guardian Wealth Advisors, Llc / Nc | Buy | +500 | +5.0% | 10,500 | $76.02K | Q1 2026 | May 15, 2026 |
| National Bank Of Canada | Sell | -227 | -38.7% | 359 | $812.00 | Q1 2026 | May 15, 2026 |
| Affinity Asset Advisors, Llc | Buy | +1,289,005 | +429.7% | 1,589,005 | $11.50M | Q1 2026 | May 14, 2026 |
| Cibc World Market Inc. | Buy | +92,900 | +160.0% | 150,950 | $1.09M | Q1 2026 | May 14, 2026 |
| 1832 Asset Management L.P. | Buy | +27,862 | +86.7% | 60,000 | $434.40K | Q1 2026 | May 14, 2026 |
| Raymond James Financial Inc | Sell | -2,412 | -4.6% | 50,560 | $366.06K | Q1 2026 | May 14, 2026 |
Frequently asked questions about EPRX activity
Which institutional owners are buying EPRX?
Institutional owners buying EPRX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in EPRX activity?
"Buy" means an investor increased their reported position in EPRX compared to the prior reporting period. This reflects growing exposure to EUPRAXIA PHARMACEUTICALS INC (EPRX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in EPRX increasing?
Institutional interest in EPRX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related EPRX Institutional Insights
- EPRX Overview
- EPRX 13F Institutional Holders
- EPRX Superinvestors
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- EPRX Insider Trading & SEC Form 4 Activity
- EPRX Articles
- Top Institutional Investor Stock Rankings